RAINBOW Rainbow Childrens Medicare Q1 FY26 results (Apr–Jun 2025) and concall
Rainbow Children's Medicare delivered a resilient Q1 FY26 performance, characterized by strong bottom-line growth despite seasonally muted volumes in general pediatrics. The company is aggressively executing its expansion strategy, with 350 beds expected to be added this year across Warangal, Bengaluru, and Rajahmundry. Management remains confident in achieving 20% revenue growth for the full year, supported by a robust cash-rich balance sheet and a shift toward high-value quaternary care.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 417 | 398 | 370 | 353 |
| EBITDA | 147 | 134 | 115 | 104 |
| Net profit | 79 | 69 | 57 | 54 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





